Vanutide cridificar

DB12132InvestigationalVaccines

Vanutide cridificar has been investigated for the treatment of Alzheimer Disease.

Mechanism: Pharmacologically active on Amyloid-beta precursor protein
Curator reviewed
Code names: ACC-001

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vanutide cridificar, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.